Dr. Elisa De Togni joined the Division of Hospital Medicine at Washington University in June 2024 as an Instructor in Medicine. She completed her undergraduate studies at Washington University in St. Louis, graduating with a bachelor’s degree in chemistry/biochemistry with Departmental Honors in Chemistry. She then pursued her medical degree at Washington University School of Medicine in St. Louis. During medical school, she received an NIH NHLBI Research Training Grant and presented her research at the American Society of Hematology conference. She actively participated in various groups, including the Music in Medicine Initiative and the Oncology student interest group, and served as a medical student liaison for the Hematology-Oncology academic course. Dr. De Togni completed her internship and residency in Internal Medicine at Washington University from 2021 to 2024. She has been involved in ongoing research in Hematology-Oncology, particularly in Bone Marrow Transplant medicine, and was recognized with the American Society of Hematology Abstract Achievement Award. She also participated in the Global Health program during her residency, gaining experience in Hematology and General Medicine practice in Accra, Ghana.
Education
BA, Chemistry-Biochemistry: Washington University, St. Louis, MO (2017)
Doctor of Medicine: Washington University, St. Louis, MO (2021)
Residency, Internal Medicine: Washington University, St. Louis, MO (2024)
Research Interests
Hematology/oncology, cardiology
Publications and Presentations
De Togni, Cole, Abboud. “Novel Approaches for Prevention and Treatment of Graft-versus-host Disease: Focus on Janus Kinase Inhibition.” Frontiers in Immunology. (Pending)
Pruitt, Gao, De Togni, Cochran, Godbole, Slade, Abboud. “Impact of Donor Age and Relationship on Outcomes of Peripheral Blood Haploidentical Hematopoietic Cell Transplantation.” Bone Marrow Transplantation. April, 2023.
Cochran…, De Togni, Abboud. “Pretransplant Desensitization for Donor-Specific Anti-HLA Antibodies Improves Overall Survival Compared to No Treatment and Produces Outcomes Equivalent to Absence of Donor-Specific Antibodies in Haploidentical Hematopoietic Cell Transplantation.” Transplantation and Cellular Therapy. 2022.
Collins, Laranjeira, Kong, De Togni, Wong, Fulbright, Fisher, Oh. “Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFkB pathway inhibition.” Blood Adv. Jan, 2022.
De Togni, Wan, Slade, Plach, Abboud. “The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Blood Stream Infections after Peripheral Blood Haploidentical Hematopoietic Cell Transplantation.” Leukemia & Lymphoma. Jul, 2022. Presented at American Society of Hematology Conference, December 10-14, 2021; Atlanta, GA USA
Zhang …, De Togni, Jez. “Biochemical Analysis of Indole-3-Acetaldehyde Dehydrogenase (AldA) from the Plant Pathogen Pseudomonas syringae PtoDC3000.” Bioscience Reports. Dec, 2020.
Bhatia…, De Togni, Schilling. “How Dynamic are Hemodynamics?: Short-Term Changes in Hemodynamic Measures and Indices among Heart Failure Patients.” The Journal of Heart and Lung Transplantation. 2019.
Husaini…, De Togni, Schilling. “Differences in Swan-Ganz Hemodynamics from Catheterization Lab Insertion to Cardiac Care Unit: A Prospective Study.” The Journal of Heart and Lung Transplantation. 2019.
De Togni, Kim, Cooper, Ritchey, O’Neal, Niswonger, DiPersio. “Chimeric Antigen Receptor T Cells Specific for CLL-1 for Treatment of Acute Myeloid Leukemia.” Blood. 2018. Presented at American Society of Hematology Conference, December 1-4, 2018; San Diego, CA USA
De Togni. “The Abolitionist’s John Brown: Martyrdom through Militancy and the Onset of Civil War.” American Battlefield Trust. 2016.
De Togni. “The Key in Lincoln’s Pocket.” American Battlefield Trust. 2013.